Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
r-ATG and Cyclosporine for Severe Aplastic Anemia
NCT01231841Phase 2Completed
- Sponsor
- Cleveland Clinic
- Start
- Mar 2005
- Primary completion
- Dec 2010
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin in aplastic anemia, sponsored by Cleveland Clinic. Started Mar 2005; status: completed.
02
Drugs
antithymocyte globulin
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT01231841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01231841.